Base: C-TRIC (Altnagelvin Hospital, Foyle Area Trust, Northern Ireland)
The University of Ulster has recently established an exciting new £11.5M Northern Ireland Centre for Stratified (Personalised) Medicine and is committed to its development as an area of excellence. The new Centre will draw together biomedical scientists, molecular biologists, biologists, doctors and computer scientists from academia, the health service and industry in their efforts to better diagnose and treat degenerative diseases including hypertension, diabetes, inflammatory disease, bone disease, neurodegenerative disease/mental illness, cancer and diseases of the eye.
The new Northern Ireland Centre for Stratified Medicine will be an integral part of, and aligned with the Institute for Health and Wellbeing based at the Magee Campus and the School of Biomedical Sciences at the Coleraine campus. The major strength of the BiomedicalSciencesSchool and Research Institute resides in its vibrant research ecosystem, teaching and learning environment and its internationally acclaimed expertise in molecular biology, biomedical science, molecular medicine, pharmacy and nutrition, with strong links with the health service, national, and international industry. The new Centre will also work closely with the recently established £5.5M Northern Ireland Centre for Functional Brain Imaging based in the Intelligent Systems Research Institute at the Magee campus.
The University wishes to appoint up to 15 dynamic self-driven research-focused lecturers with expertise in Stratified Medicine (molecular biology/biochemistry/ clinical/research or biostatistics, systems biology) within this new Centre based on the AltnagelvinHospital site in the Clinical Translational Research and Innovation Centre (C-TRIC). The postholders will deliver on the objectives of a series of disease-focused work packages associated with a major generously funded stratified medicine project working at the interface between systems biology/bioinformatics, genomics and medicine. Core duties will be research focused, but will also include delivery of innovative new specialist undergraduate and postgraduate taught provision in the area of stratified medicine and will involve close engagement with end users including the health service, and the pharmaceutical and diagnostics industry. Applicants must have research outputs at 3/4 level eligible for inclusion in REF 2014, possibly as an early career researcher.
All posts are available at an early date mutually convenient to the University and the successful applicants however, the successful applicants must be available to take up post prior to 31st October 2013.
A generous start-up support package is available.
The closing date for receipt of completed applications is 15th July 2013.
We prefer to issue and receive applications via the 'Apply' button below.
Hard copy applications can be obtained by telephoning 028 7012 4072.
The University is an equal opportunities employer and welcomes applicants from all sections of the community, particularly from those with disabilities. Appointment will be made on merit.
